Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 09, 2026 5.754
October 08, 2026 6.298
October 07, 2026 6.800
October 06, 2026 7.047
October 05, 2026 7.132
October 02, 2026 6.969
October 01, 2026 7.481
September 30, 2026 7.435
September 29, 2026 8.538
September 28, 2026 6.660
September 25, 2026 6.980
September 24, 2026 6.891
September 23, 2026 8.454
September 22, 2026 10.52
September 21, 2026 14.59
September 18, 2026 11.68
September 17, 2026 10.19
September 16, 2026 9.117
September 15, 2026 9.117
September 14, 2026 10.33
September 11, 2026 9.580
September 10, 2026 11.33
September 09, 2026 9.371
September 08, 2026 9.248
September 04, 2026 9.433
Date Value
September 03, 2026 9.428
September 02, 2026 9.417
September 01, 2026 9.924
August 31, 2026 9.913
August 28, 2026 9.728
August 27, 2026 9.658
August 26, 2026 9.516
August 25, 2026 9.787
August 24, 2026 9.857
August 21, 2026 10.57
August 20, 2026 10.70
August 19, 2026 11.08
August 18, 2026 11.21
August 17, 2026 11.32
August 14, 2026 11.27
August 13, 2026 12.33
August 12, 2026 12.18
August 11, 2026 27.75
August 10, 2026 40.22
August 07, 2026 50.14
August 06, 2026 48.00
August 05, 2026 48.26
August 04, 2026 50.95
August 03, 2026 52.29
July 31, 2026 50.41

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
BioLineRx Ltd. 0.703
XTL Biopharmaceuticals Ltd. --
Kamada Ltd. 1.729
Can-Fite BioPharma Ltd. 1.380
Eocene Ltd. 0.2783

Price to Book Value Related Metrics

Price 0.2146
Earnings Yield -26.35K%
Market Cap 0.2532M